Soligenix, Inc. (SNGX)
1.63
+0.03
(+1.88%)
USD |
NASDAQ |
Dec 11, 16:00
1.63
0.00 (0.00%)
Pre-Market: 08:30
Soligenix Free Cash Flow: -9.758M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Amicus Therapeutics, Inc. | 9.691M |
| Insmed, Inc. | -906.14M |
| Tonix Pharmaceuticals Holding Corp. | -78.87M |
| Citius Oncology, Inc. | -0.3641M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.933M |
| Cash from Investing (Quarterly) | -0.0006M |
| Cash from Financing (Quarterly) | 8.361M |
| Free Cash Flow Per Share (Quarterly) | -0.6775 |
| Free Cash Flow to Equity (Quarterly) | -2.907M |
| Free Cash Flow to Firm (Quarterly) | -2.933M |
| Free Cash Flow Yield | -181.8% |